Shania M. Corry

Roosevelt Drive
Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Therapeutic manipulation and spatial quantification of the tumor microenvironment in colorectal cancer.

Therapeutic manipulation and spatial quantification of the tumor microenvironment in colorectal cancer.

Journal: iScience
Published: December 15, 2025

Stromal cells modulate innate immune cell phenotype and function in colorectal cancer via the Sialic acid/Siglec axis.

Stromal cells modulate innate immune cell phenotype and function in colorectal cancer via the Sialic acid/Siglec axis.

Journal: Journal for immunotherapy of cancer
Published: September 15, 2025

Viral mimicry redirects immunosuppressed colorectal tumour landscapes towards a proinflammatory and CMS1-like regenerative state.

Viral mimicry redirects immunosuppressed colorectal tumour landscapes towards a proinflammatory and CMS1-like regenerative state.

Journal: Communications biology
Published: July 08, 2025

MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.

MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.

Journal: Nature
Published: December 10, 2024

Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.

Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.

Journal: Nature genetics
Published: June 03, 2024

Dual gene set enrichment analysis (dualGSEA); an R function that enables more robust biological discovery and pre-clinical model alignment from transcriptomics data.

Dual gene set enrichment analysis (dualGSEA); an R function that enables more robust biological discovery and pre-clinical model alignment from transcriptomics data.

Journal: Scientific reports
Published: May 21, 2024

Tumor-associated mesenchymal stromal cells modulate macrophage phagocytosis in stromal-rich colorectal cancer via PD-1 signaling.

Tumor-associated mesenchymal stromal cells modulate macrophage phagocytosis in stromal-rich colorectal cancer via PD-1 signaling.

Journal: iScience
Published: January 04, 2024

Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.

Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.

Journal: Nature genetics
Published: December 04, 2022

MmCMS: mouse models' consensus molecular subtypes of colorectal cancer.

MmCMS: mouse models' consensus molecular subtypes of colorectal cancer.

Journal: British journal of cancer
Published: June 03, 2022

Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinical Data.

Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinical Data.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 07, 2022

Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer.

Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer.

Journal: Gut
Published: September 23, 2021

Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment.

Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment.

Journal: Cell reports
Published: August 05, 2021
Showing 1-12 of 12

Last Updated: 09/26/2026